Skip to main content

COVID-19 Topic Center

HIV/AIDS Expert Insights

First Report Managed Care
By Julie Gould  According to recent study findings publishing online in Ageing Research Reviews, older adults with HIV infection are at increased risk of cognitive impairment. More specifically, this patient population is more at risk for cognitive impairment within the following domains:  …
First Report Managed Care
By Julie Gould  Jenn Zerbato, PhD, post-doctoral research fellow, Peter Doherty Institute for Infection and Immunity, breaks down why HIV RNA could serve as a better measure of efficient latency reversal in both pre-clinical and clinical assessment of latency reversing agents (LRAs). What…
First Report Managed Care
Max Lataillade, DO, head of global research strategy, ViiV Healthcare, discusses the findings of the BRIGHTE study that demonstrated a significant decrease in HIV-1 RNA levels among patients treated with fostemsavir, a first-in-class investigational HIV-1 attachment inhibitor.   Disclosure…
First Report Managed Care
HIV is still a major public health problem in the United States. Data from the Centers for Disease Control and Prevention (CDC) estimate that 1.1 million persons in the United States are currently living with HIV,1 including an estimated 15% of individuals with the disease who are unware of their…
First Report Managed Care
More generic HIV medications are entering the marketplace creating potential for significant cost savings; however, a series of complex and unique barriers facing these medications could slow their use, adoption, and impact in the United States. In recent years, generic versions of lamivudine,…
Back to Top